Annual Drug Patent Expirations for PLIAGLIS
Pliaglis is a drug marketed by Taro Pharms and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.
This drug has six patent family members in six countries.
The generic ingredient in PLIAGLIS is lidocaine; tetracaine. Two suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
